0000899243-18-003897.txt : 20180214
0000899243-18-003897.hdr.sgml : 20180214
20180214175031
ACCESSION NUMBER: 0000899243-18-003897
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180213
FILED AS OF DATE: 20180214
DATE AS OF CHANGE: 20180214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kuno Sachiko
CENTRAL INDEX KEY: 0001383384
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33609
FILM NUMBER: 18614362
MAIL ADDRESS:
STREET 1: 7501 WISCONSIN AVENUE
STREET 2: SUITE 600E
CITY: BETHESDA
STATE: MD
ZIP: 20814
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sucampo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001365216
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133929237
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 805 KING FARM BOULEVARD, SUITE 550
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 3019613400
MAIL ADDRESS:
STREET 1: 805 KING FARM BOULEVARD, SUITE 550
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-02-13
1
0001365216
Sucampo Pharmaceuticals, Inc.
SCMP
0001383384
Kuno Sachiko
28307 MALLARD DRIVE
EASTON
MD
21601
0
0
1
0
Class A Common Stock
2018-01-25
5
G
0
E
2000000
0.00
D
5137344
I
By SK Impact Fund, LLC
Class A Common Stock
2018-02-13
4
U
0
5137344
18.00
D
0
I
By SK Impact Fund, LLC
Disposed of upon expiration of the tender offer conducted by Sun Acquisition Co., a Delaware corporation ("Purchaser"), pursuant to the terms of the Agreement and Plan of Merger, dated as of December 26, 2017, among Sucampo Pharmaceuticals, Inc., a Delaware corporation (the "Issuer"), Mallinckrodt plc, an Irish public limited company ("Parent"), and Purchaser, a wholly owned subsidiary of Parent, whereby Purchaser offered to purchase each outstanding share of Class A Common Stock, par value $0.01 per share, of the Issuer at a purchase price of $18.00 per share in cash, subject to any required withholding of taxes and without interest.
/s/ Kei Tolliver, by Power of Attorney
2018-02-14